BioCatalyst

CT7439 Capsules (0.5 mg, 1mg, 3mg, 10mg, 15mg, 20mg) — catalyst calendar

1 verified catalyst event(s) referencing CT7439 Capsules (0.5 mg, 1mg, 3mg, 10mg, 15mg, 20mg), each linked to its official source. Verified as of 2026-11-02.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-03-14
in 4mo
ESTIMATED
 READOUT
A Modular Phase 1/2 Study With CT7439 in Participants With Solid Malignancies
Phase 1/2 · Solid Malignancies
 Carrick Therapeutics Limited CT7439 Capsules (0.5 mg, 1mg, 3mg, 10mg, ClinicalTrials.gov ↗
✓ Source-checked 2026-11-02
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.